REMS programs need to address stakeholder usability
Heather Morel
Advertisement
Articles by Heather Morel
Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations
Advertisement
Latest Updated Articles
- Dealing With REMS Challenges in Drug Commercialization
Published: August 19th 2009 | Updated:
- Smoothing the Path to Drug Safety
Published: June 28th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
US and UK Agree to Zero Tariffs on Pharmaceuticals
2
How DSCSA Compliance Is Unlocking Recall Efficiency
3
New HTI-4 Final Rule Sets Path for Modernized Prescribing and Patient Access
4
Pharma Pulse: US-UK Trade Deal Forces Pricing Shift, as Lilly Deepens GLP-1 Price Cuts and RSV-Asthma Link Confirmed
5
